Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market CAGR Analysis And Future Market Development
The artificial intelligence (AI)-driven hospital readmission predictor market has seen rapid expansion in recent years. It is anticipated to grow from $1.92 billion in 2025 to $2.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.2%. The growth observed in the historic period is attributable to the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the expansion of predictive analytics usage, and an increasing focus on patient outcomes.
The artificial intelligence (AI)-driven hospital readmission predictor market is anticipated to undergo significant expansion in the coming years. It is projected to achieve a size of $6.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 25.9%. This expansion throughout the forecast period is attributable to increasing investments in healthcare IT infrastructure, the growing incorporation of clinical decision support systems, the rising adoption of cloud-based analytics platforms, the broadening scope of remote patient monitoring tools, and an enhanced focus on value-based care models. Key trends during this period are expected to include technological advancements in machine learning models, innovations in real-time patient monitoring, research and developments in natural language processing, the creation of explainable AI specifically for healthcare, and improvements in interoperable healthcare IT systems.
Download A Free Sample Report For Comprehensive Market Insights:
#Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Growth Drivers And Industry Catalysts
The growing incidence of chronic ailments is projected to boost the artificial intelligence (AI)-driven hospital readmission predictor market. Chronic diseases, defined as enduring health issues such as diabetes, heart disease, and arthritis, typically progress slowly and necessitate ongoing medical attention and lifestyle adjustments to manage symptoms and avert complications. The rise in these conditions is largely attributed to unhealthy lifestyle choices, including inadequate diet, physical inactivity, and smoking, which escalate the likelihood of ailments like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors play a crucial role in chronic disease management by analyzing patient information to pinpoint individuals at high risk of readmission. They enhance patient outcomes by facilitating proactive interventions, tailored care plans, and timely follow-ups, thereby preventing complications and shortening hospital stays. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Segmentation And Category Breakdown
The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud
3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools
2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices
3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services
#Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Trends Influencing Long-Term Demand
Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are prioritizing the development of sophisticated solutions, such as advanced predictive modeling, to pinpoint high-risk patients, enable swift interventions, and optimize post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to uncover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution, which integrates advanced predictive modeling to identify avoidable readmissions among Medicare, Medicaid, and uninsured populations. The platform also delivers unified 360-degree patient views, agentic AI tools like Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for planning proactive interventions. This solution supports healthcare providers in decreasing readmission rates, enhancing resource allocation, and improving overall patient outcomes.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Competitive Analysis Of Major Industry Participants
Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx
Access The Complete Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Geographic Distribution And Regional Opportunities
North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model